sgt-003
Gene therapyexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jan 15, 2024 (NCT06138639)
Timeline
Indications
Studied for
Mechanism of action
- Dystrophin pre-mRNASupplementation
Dystrophin pre-mRNA supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07160634 | Phase 3 | Oct 31, 2025 | Solid Biosciences |
| NCT06138639 | Phase 1/Phase 2 (Phase 2) | Jan 15, 2024 | Solid Biosciences |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Solid Biosciences | For profit | 2 | 2 | 2 | 2024 |
1 organizations
Page 1 / 1